agonistas de glp 1 Fundación RedGDPS Agonistas GLP-1: La Ciencia Detrás
Description
Dupixent (dupilumab) Disease area(s): Immunology/respiratory Manufacturer(s): Sanofi/Regeneron 2024 Sales (USD): $14.15 billion Why it sold so well: Co-developed by Sanofi and Regeneron, Dupixent achieved significant success in 2024, with global net sales reaching $14.15 billion a 22% increase over 2023
Celebrity discussions and Super Bowl commercials featuring Serena Williams, Kenan Thompson, and DJ Khaled followed
ApoB, the protein that packages cholesterol into particles for transport, acts like a fleet of delivery trucks
Bucheit J, Ayers J, Pamulapati L, Browning A, Sisson E
